BackCyteir Therapeutics Overview

Cyteir Therapeutics Cost of Revenue

Cost of Revenue analysis for CYT.

Quarterly Cost of Revenue

$100000.00
↓ 50% YoY

As of Sep 30, 2023

Annual Cost of Revenue (TTM)

$834000.00
↑ 108.5% YoY

Trailing 12 months ending Sep 30, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin